Want to Make the Big Bucks in R&D? Join the Industry
Tuesday, August 25, 2015
Source: Fierce Biotech
When George Yancopoulos walked away from Columbia University to join Regeneron ($REGN) in 1989, the decision to leave academia for industry was at least partly motivated by the pay differential. The move paid off and then some, with Yancopoulos becoming the first billionaire biopharma R&D head at a time when the best-paid research institute chiefs are pulling in just north of $1 million a year.